Vicor Corporation just delivered one of its sharpest weekly moves in recent memory — up 37% in five sessions to close at $332.95, after a 24% single-day jump. The setup is a classic short-versus-momentum collision: a meaningful short position caught fully off-side by a stock rocketing to new highs.
The squeeze dynamic is written across the short interest data. Short interest in VICR peaked above 7% of free float in late April and into early May, when the stock was still well below current levels. As the rally took hold, shorts covered aggressively — SI declined from roughly 7% in the first week of May to 6.0% of free float by May 26, the lowest reading in the two-month window. That's still a substantive position, but the direction of travel is clear: shorts have been retreating, not pressing. The borrow market confirms there is no meaningful squeeze pressure left — cost to borrow has actually eased, falling 20% over the week to a negligible 0.38%. Availability runs at over 1,600%, meaning the lending pool is essentially wide open for anyone wanting to initiate or rebuild a short.
Options positioning has rotated sharply in line with the price action. The put/call ratio has dropped to 0.68, well below its 20-day average of 0.79 — more than one standard deviation to the bullish side. That's a meaningful shift from April, when PCR readings consistently sat above 0.85, reflecting far more defensive hedging. Call demand has clearly picked up as the stock surged, which either reflects new bulls buying upside or shorts hedging against further pain.
The Street's relationship with VICR is awkward right now. The most recent analyst action on record came from Needham in late April, when the firm raised its target to $260 from $180 while maintaining a Buy. That target is now trading below the stock. Roth Capital initiated coverage in late 2025 at $115 and raised to $175 in January 2026 — both figures now firmly in the rearview mirror. The consensus mean price target is $323.75, fractionally below current levels, which implies the Street has essentially no further upside pencilled in at this price. The bull case centres on Vicor's patent-protected power delivery technology and growing Gen 5 customer adoption, with EPS momentum scores ranking in the 78th and 90th percentiles over 30 and 90-day windows respectively — genuinely strong earnings revision trends. Bears flag the heavy concentration in a handful of customers, founder control (CEO Patrizio Vinciarelli holds nearly 44% of shares), and a P/E of 85x that leaves little margin for error. EV/EBITDA has jumped to 61x, up roughly 9 points over the past month as the price ran.
Insider activity adds a layer of complexity. Across May 12-14, multiple insiders sold into the rally — the CIO, the Chief Accounting Officer, a VP, and a director all reduced positions, with combined sales in the window of roughly $2.4 million. The 90-day net is technically positive at +46,742 shares and ~$14 million in value, but that figure is dominated by the founder's substantial base position rather than fresh buying from management. The more recent pattern — selling by officers at prices between $287 and $316 — is worth noting given where the stock is trading today. T. Rowe Price added 1.45 million shares as of end-March, a notable institutional commitment that predated much of this rally.
The April 21 earnings print is the clearest precedent in the data: the stock moved 18% on the day and added another 11% over the following five sessions. That post-earnings momentum carried forward and helped build the conditions for this week's extension. The ORTEX short score of 39, in roughly the 32nd percentile, suggests the overall short setup is not extreme by historical standards — the covering that happened through May has taken pressure off.
What to watch now is whether the analyst community updates its targets to reflect the new price level, and whether insider selling activity picks up further as officers face a stock trading at a significant premium to any published estimate.
See the live data behind this article on ORTEX.
Open VICR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
